| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,007,500 | 956,900 | 859,700 | 913,700 | | Cost of Revenue | 611,900 | 610,700 | 540,100 | 565,100 | | | Gross Profit | 395,600 | 346,200 | 319,600 | 348,600 | | | Operating Expenses | | Research Development | 57,900 | 52,900 | 50,000 | 53,500 | | Selling General and Administrative | 162,400 | 146,300 | 145,500 | 139,400 | | Non Recurring | 13,800 | 55,900 | 9,400 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 161,500 | 91,100 | 114,700 | 155,700 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (100) | (14,500) | 300 | (600) | | Earnings Before Interest And Taxes | 161,400 | 76,600 | 115,000 | 155,100 | | Interest Expense | 25,100 | 28,200 | 26,900 | 29,000 | | Income Before Tax | 136,300 | 48,400 | 88,100 | 126,100 | | Income Tax Expense | 20,100 | 22,900 | (77,400) | 21,500 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 116,200 | 25,500 | 165,500 | 104,600 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 116,200 | 25,500 | 165,500 | 104,600 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $116,200 | $25,500 | $165,500 | $104,600 |
|
0.00% Nasdaq 
Income Statement
